Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

SynAct Pharma AB

SYNACT
Current price
7.8 SEK -0.21 SEK (-2.56%)
Last closed 8 SEK
ISIN SE0008241491
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 331 141 807 SEK
Yield for 12 month +12.64 %
1Y
3Y
5Y
10Y
15Y
SYNACT
21.11.2021 - 28.11.2021

SynAct Pharma AB, a clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden. The company develops AP1189, a drug candidate in Phase 2 clinical trial for the treatment of rheumatoid arthritis, idiopathic membranous nephropathy, and virus-induced respiratory insufficiency. It is developing TXP-11, an advanced peptide agonist that is in preclinical trials for the prevention of organ failure in surgery; and various drug programs to treat auto-immune and inflammatory diseases. SynAct Pharma AB was founded in 2012 and is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 81

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

163 SEK

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-779 811 SEK

Last Year

-1 066 477 SEK

Current Quarter

Last Quarter

Key Figures SYNACT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -64 508 967 SEK
Operating Margin TTM
PE Ratio
Return On Assets TTM -18.94 %
PEG Ratio
Return On Equity TTM -81.55 %
Wall Street Target Price 163 SEK
Revenue TTM
Book Value 4.11 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -4.34 SEK
Diluted Eps TTM -4.34 SEK
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SYNACT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SYNACT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation SYNACT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -22.2456
Price Book MRQ 1.953

Financials SYNACT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SYNACT

For 52 weeks

4.99 SEK 13.83 SEK
50 Day MA 8.94 SEK
Shares Short Prior Month
200 Day MA 8.11 SEK
Short Ratio
Shares Short
Short Percent